Literature DB >> 19956503

Correlative effect between in vivo hollow fiber assay and xenografts assay in drug screening.

Keyong Ho Lee1, Ki Hyeong Rhee.   

Abstract

PURPOSE: This study was carried out to assess the usage of an in vivo hollow fiber assay to screen drugs with highly predictive accuracy.
MATERIALS AND METHODS: The assay systems used were the hollow fiber and xenografts assays. The hollow fiber assay was carried out with the following steps; preparation of fibers, preparation of cells, loading and implanting fibers, treatment with drugs, removal of fibers and assaying for the cell viability by the MTT assay. For the xenografts assay, cell suspensions were subcutaneously transplanted into the mice. Therapy was started when the tumor volume reached 100 approximately 200 mm(3). The tumor volumes were calculated using the formula V=[length+(width)(2)]/2, and used for evaluating the efficacy of the drugs. The drug treatment doses used were adriamycin 2.1 mg/kg, mitomycin-C 0.25 mg/kg, 5-fluorouracil 24.5 mg/kg and paclitaxel 2.5 mg/kg, and administrated intravenously five times daily.
RESULTS: The correlation between the xenografts and hollow fiber assays was evaluated in 20 tumor cell lines and 4 anti-cancer agents. In the 20 tumor cell lines, the overall predictive accuracy of the hollow fiber assay for sensitivity was 83%, with a predictive accuracy for resistance of 92%.
CONCLUSION: The hollow fiber assay was assessed as effective in drug efficacy evaluation, and found to be compatible with that of the xenografts assay.

Entities:  

Keywords:  Correlation; Drug screen; Hollow fiber assay; Xenografts assay

Year:  2005        PMID: 19956503      PMCID: PMC2785405          DOI: 10.4143/crt.2005.37.3.196

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  24 in total

1.  Characterization of a new in vivo hollow fiber model for the study of progression of prostate cancer to androgen independence.

Authors:  Marianne D Sadar; Violetta A Akopian; Eliana Beraldi
Journal:  Mol Cancer Ther       Date:  2002-06       Impact factor: 6.261

2.  Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.

Authors:  Muthusamy Jayaraman; Brian M Fox; Melinda Hollingshead; Glenda Kohlhagen; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2002-01-03       Impact factor: 7.446

3.  Synthesis of imidazo[1,5,4-de]quinoxalin-9-ones, benzimidazole analogues of pyrroloiminoquinone marine natural products.

Authors:  Daniel V Labarbera; Edward B Skibo
Journal:  Bioorg Med Chem       Date:  2005-01-17       Impact factor: 3.641

4.  In vivo drug screening applications of HIV-infected cells cultivated within hollow fibers in two physiologic compartments of mice.

Authors:  M Hollingshead; J Roberson; W Decker; R Buckheit; C Elder; L Malspeis; J Mayo; M Grever
Journal:  Antiviral Res       Date:  1995-11       Impact factor: 5.970

5.  A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.

Authors:  Stanley Kupchinsky; Sara Centioni; Tiffany Howard; John Trzupek; Shane Roller; Virginia Carnahan; Heather Townes; Bethany Purnell; Carly Price; Heather Handl; Kaitlin Summerville; Kimberly Johnson; James Toth; Stephen Hudson; Konstantinos Kiakos; John A Hartley; Moses Lee
Journal:  Bioorg Med Chem       Date:  2004-12-01       Impact factor: 3.641

6.  Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.

Authors:  L V Rubinstein; R H Shoemaker; K D Paull; R M Simon; S Tosini; P Skehan; D A Scudiero; A Monks; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

7.  Characteristics of 85 pediatric tumors heterotransplanted into nude mice.

Authors:  J E Neely; E T Ballard; A L Britt; L Workman
Journal:  Exp Cell Biol       Date:  1983

8.  In vivo cultivation of tumor cells in hollow fibers.

Authors:  M G Hollingshead; M C Alley; R F Camalier; B J Abbott; J G Mayo; L Malspeis; M R Grever
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

9.  The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.

Authors:  Ke Hu; Xinsheng Yao
Journal:  Phytother Res       Date:  2003-06       Impact factor: 5.878

10.  Heterotransplantation of small-cell carcinoma of the lung into nude mice: comparison of intracranial and subcutaneous routes.

Authors:  A F Gazdar; D N Carney; H L Sims; A Simmons
Journal:  Int J Cancer       Date:  1981-12       Impact factor: 7.396

View more
  2 in total

1.  Preclinical efficacy testing for stomach and liver cancers.

Authors:  Jun Won Park; Nam Suk Baek; Seok Cheol Lee; Su Jin Oh; Seok Hoon Jang; In Hoo Kim; Dae Yong Kim; Hark Kyun Kim
Journal:  Cancer Res Treat       Date:  2014-04-22       Impact factor: 4.679

2.  Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.

Authors:  Feifei Zhang; Wenjie Wang; Yuan Long; Hui Liu; Jijun Cheng; Lin Guo; Rongyu Li; Chao Meng; Shan Yu; Qingchuan Zhao; Shun Lu; Lili Wang; Haitao Wang; Danyi Wen
Journal:  Cancer Commun (Lond)       Date:  2018-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.